You searched for "macular"
Do bilateral same day intravitreal injections increase the risk of endophthalmitis?
1 February 2019
| Tasmin Berman
|
EYE - Vitreo-Retinal
This large retrospective cohort study reviewed all patients who had bilateral intravitreal anti-vascular endothelial growth factor (VEGF) injections between April 2012 and August 2017. There were 101,932 procedures performed in 5890 patients. The two most common indications for injections were...
OCT measurements in neurodevelopmental conditions
The authors aimed to investigate what changes occur in the retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and macula when specific learning disorder (SLD) comorbidity is added to attention deficit hyperactivity disorder (ADHD). They compared measures in three...Case report of Leber hereditary optic neuropathy (LHON)
1 October 2016
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Central scotoma, Leberhereditary optic neuropathy, macular hole
This case report presents a 74-year-old male patient who developed LHON, with a previous diagnosis of bilateral macular holes. LHON occurs predominantly in healthy young men and onset in older age ranges increases the likelihood that the patient will have...
Vitreomacular traction: natural course vs. vitrectomy vs. ocriplasmin
3 June 2024
| Haider Manzar
|
EYE - Vitreo-Retinal
Over time, the vitreous gel completely separates from the retina in a process known as a posterior vitreous detachment (PVD). In some instances, however, the vitreous does not detach entirely and remains adherent to the macula. The term vitreomacular traction...
Two-year results of a T&E aflibercept regime in caucasian PNV
4 October 2023
| Su Young
|
EYE - Vitreo-Retinal
This a retrospective study examining two-year outcomes of patients with pachychoroid neovasculopathy (PNV) treated with a treat and extend (T&E) regimen of intravitreal aflibercept. The mean age was 63.84 ± 7.92 years with nine males (35%) and 17 females (65%)....
Moorfields Education: The Macula course 2024
3 June 2024
-6 June 2024
The course aims to provide a comprehensive and up-to-date review of retinal and macular diseases and their management, including new developments.
Moorfields Education: Implementing a non-medical intravitreal injection service (Nov 23)
17 November 2023
This course is for clinicians working in an ophthalmic or medical retina setting, focusing on the treatment of age-related macular degeneration, retinal vein occlusion and diabetic oedema.
New partnership to prevent unnecessary sight loss
13 December 2022
Sight loss charity the Macular Society has announced a new partnership with OcuPlan, a service designed to give patients with long-term eye conditions such as macular disease affordable access to specialist care to prevent unnecessary sight loss.
Melphalon treatment of retinoblastoma
The purpose of this study was to report the authors’ experience with superselective ophthalmic artery infusion of Melphalon (SOAIM) for the treatment of five cases of unilateral sporadic retinoblastoma involving the macula. Standard therapy included a cycle of three infusions...Retinoschisis
2 December 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this retrospective study the authors evaluate the effect of pars plana vitrectomy (PPV) and internal limiting membrane (ILM) peeling for lamellar macular hole (LMH) with or without macular retinoschisis in highly myopic eyes. Twenty-one highly myopic patients (22 eyes)...
Glaucoma and capillary perfusion
1 August 2019
| Kurt Spiteri Cornish
|
EYE - Glaucoma
|
Glaucoma, OCTA, field of vision, intraocular pressure, macula, optic nerve
Elevated IOP is important but not the sole factor responsible for retinal ganglion cell (RGC) death and optic nerve damage in glaucoma. There is increasing evidence that visual loss correlates with macular inner retinal thinning. A total of 148 eyes...
Comparison of retinal pigment epithelium-choroid graft surgery and anti-VEGF therapy in patients with wet AMD
1 December 2015
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This was a randomised intervention study in wet AMD patients to investigate benefits of free RPE-choroid graft transplantation surgery versus (continuation of) anti-VEGF treatment. Twenty patients who met the inclusion criteria were subdivided into three subgroups, i.e. RPE tears involving...